Article Details
Retrieved on: 2022-08-04 16:14:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Lackluster initial results forces Pfizer to discontinue Phase III trial on a potential drug for symptomatic dilated cardiomyopathy (DCM).
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here